Abstract:As a specific microvascular complication of diabetes, diabetic retinopathy (DR) causes severe visual impairment in patients with diabetes. The expression of microRNA‑126 (miRNA/miR‑126) has previously been found to be significantly decreased in the serum of patients with DR. In the present study, the functions of miR‑126 and its mechanisms of action in experimental diabetic retinopathy were examined in rats with streptozotocin (STZ)‑induced diabetes and in high glucose (HG)‑induced human retinal capillary endothelial cells (HRCECs). In vivo, diabetic rat models were established and the rats were intravitreally injected with lentivirus expressing rno‑miR‑126 (lenti‑miR‑126) or negative control (lenti‑NC). RT‑qPCR was used to determine the miR‑126 level in the serum and retina. Paraffin sections and retinal vasculature were used to determine the extent of retinopathy. The protein content of vascular endothelial growth factor (VEGF) and pigment epithelium‑derived factor (PEDF) in the retina was used as an auxiliary measurement of retinopathy. Western blot analysis and immunofluorescence staining were used to measure the expression of polo‑like kinase 4 (PLK4) in rat retinal tissue. In vitro, the cells were transfected with miR‑126 inhibitor or mimic and treated with the PLK4 inhibitor, CFI‑400945 fumarate. RT‑qPCR and western blot analysis were used to detect the miR‑126 level and PLK4 expression. Cell proliferation and migration were measured by EdU and Transwell assays. The diabetic rats were found to exhibit downregulated serum and retinal miR‑126 levels compared with the non‑diabetic rats. The intravitreal delivery of miR‑126 alleviated retinopathy and reduced the diabetes‑induced upregulation of PLK4 in retinal tissues. Luciferase reporter assays confirmed that PLK4 mRNA was the target of miR‑126. In HG‑induced HRCECs, transfection with miR‑126 mimic increased the miR‑126 level, whereas it downregulated that of its downstream target, PLK4, which was opposite to the effects exerted by the miR‑126 inhibitor. Furthermore, miR‑126 mimic and CFI‑400945 fumarate reduced the HG‑induced upregulation of PLK4 expression, as well as cell proliferation and migration. On the whole, the findings of the present study demonstrate that miR‑126 reduces experimental diabetic retinopathy and suppresses endothelial cell proliferation and migration by targeting PLK4. Thus, miR‑126 and CFI‑400945 fumarate may be therapeutic targets for DR.

Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy

Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression

Exosomes derived from BMSCs alleviates high glucose‐induced diabetic retinopathy via carrying miR‐483‐5p

Mesenchymal Stem Cell Exosomal miR-146a Mediates the Regulation of the TLR4/MyD88/NF-κB Signaling Pathway in Inflammation due to Diabetic Retinopathy

Mesenchymal Stem Cell Exosomal miR-146a Mediates the Regulation of the TLR4/MyD88/NF- κ B Signaling Pathway in Inflammation due to Diabetic Retinopathy

MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p/XBP1 axis

MiRNA-144-3p Inhibits High Glucose Induced Cell Proliferation Through Suppressing FGF16.

Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.

Mesenchymal stem cells-derived exosomes alleviate senescence of retinal pigment epithelial cells by activating PI3K/AKT-Nrf2 signaling pathway in early diabetic retinopathy

Mesenchymal Stem Cell-derived Exosomal miR-125b-5p Suppressed Retinal Microvascular Endothelial Cell Ferroptosis by Targeting P53 in Diabetic Retinopathy

miR-29b Modulates Bone Marrow Mesenchymal Stem Cells (BMSCs) Differentiation and Induces Nerve Repair in Diabetic Retina Rat Model

Upregulation of miR‐192‐5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy

MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR/PI3K/AKT pathway

Bone marrow mesenchymal stem cell‐derived exosomal miR‐221‐3p promotes angiogenesis and wound healing in diabetes via the downregulation of forkhead box P1

Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt/ b-catenin signaling pathway

MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor expression

The exosome-transmitted lncRNA LOC100132249 induces endothelial dysfunction in diabetic retinopathy

Roles of Wnt/β-Catenin Signaling in Retinal Neuron-Like Differentiation of Bone Marrow Mesenchymal Stem Cells from Nonobese Diabetic Mice

MicroRNA-148a-3p alleviates high glucose-induced diabetic retinopathy by targeting TGFB2 and FGF2

MicroRNA‐126 suppresses the proliferation and migration of endothelial cells in experimental diabetic retinopathy by targeting polo‐like kinase 4

MiR-124-3p Suppresses the Dysfunction of High Glucose-Stimulated Endothelial Cells by Targeting G3BP2